ES2525342T3 - Inmunoensayo para antidepresivos basados en N-(3-clorofenil)piperazina - Google Patents

Inmunoensayo para antidepresivos basados en N-(3-clorofenil)piperazina Download PDF

Info

Publication number
ES2525342T3
ES2525342T3 ES09162439.5T ES09162439T ES2525342T3 ES 2525342 T3 ES2525342 T3 ES 2525342T3 ES 09162439 T ES09162439 T ES 09162439T ES 2525342 T3 ES2525342 T3 ES 2525342T3
Authority
ES
Spain
Prior art keywords
chlorophenyl
piperazine
immunoassay
substituted
antidepressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09162439.5T
Other languages
English (en)
Inventor
Stephen Fitzgerald
Elouard Benchikh
Ivan McConnell
Philip Lowry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Application granted granted Critical
Publication of ES2525342T3 publication Critical patent/ES2525342T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9466—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un anticuerpo utilizado para detectar o determinar N-(3-clorofenil)piperazina y N'-sustituidas-N-(3- clorofenil)piperazinas en una solución o en una muestra in vitro tomada de un paciente, que se caracteriza por haber sido producida a partir de un inmunógeno de estructura I y además también se caracteriza por ser capaz de unirse a un epítopo de N-(3-clorofenil)piperazina o la fracción N-(3-clorofenil)piperazina de una N'-sustituida N-(3- clorofenil)piperazina. Estructura I, donde "accm" es la abreviatura de material portador que confiere antigenicidad.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES09162439.5T 2009-06-10 2009-06-10 Inmunoensayo para antidepresivos basados en N-(3-clorofenil)piperazina Active ES2525342T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20090162439 EP2261259B1 (en) 2009-06-10 2009-06-10 Immunoassay for N-(3-chlorophenyl)piperazine-based anti-depressants

Publications (1)

Publication Number Publication Date
ES2525342T3 true ES2525342T3 (es) 2014-12-22

Family

ID=40854252

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09162439.5T Active ES2525342T3 (es) 2009-06-10 2009-06-10 Inmunoensayo para antidepresivos basados en N-(3-clorofenil)piperazina

Country Status (2)

Country Link
EP (1) EP2261259B1 (es)
ES (1) ES2525342T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910031D0 (en) * 2009-06-11 2009-07-22 Randox Lab Ltd Mcpp immunoassay
GB201203266D0 (en) 2012-02-24 2012-04-11 Randox Lab Ltd Assay for the detection of the phenylpiperazine family
GB201211634D0 (en) * 2012-06-28 2012-08-15 Randox Lab Assay for benzylpiperazine and metabolites
AU2013305970B2 (en) * 2012-08-21 2017-08-17 Saladax Biomedical Inc. Antibodies to aripiprazole haptens and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay

Also Published As

Publication number Publication date
EP2261259A1 (en) 2010-12-15
EP2261259B1 (en) 2014-07-30

Similar Documents

Publication Publication Date Title
ES2507520T3 (es) Aislamiento y/o identificación de células madre con potencial de diferenciación adipocitario, condrocitario y pancreático
ES2649612T3 (es) Un procedimiento para la preparación del nitrilo de ácido 2-hidroxi-4-(metiltio)butírico a partir del 3-(metiltio)propanal y de cianuro de hidrógeno
AR075896A1 (es) Anticuerpos anti-her (factor de crecimiento epidermico)
CL2016002624A1 (es) Anticuerpos humanos que se unen al gen 3 de activación linfocitaria (lag-3) y los usos de estos (divisional sol. n°0308-2011)
MX2015012825A (es) Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
MA33256B1 (fr) Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
CR20110091A (es) Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos
CO6751288A2 (es) Composición antigénica de micobacteria
AR054474A1 (es) Formulacion de anticuerpos estables
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
AR048599A1 (es) Anticuerpos anti-p-selectina
CO6280567A2 (es) Establecimiento de un anticuerpo monoclonal para detector de proteinas pag en la circulacion
MX2019005150A (es) Inhibidores de la tirosina-cinasa de bruton.
BRPI0410261A (pt) método de detecção de probnp natural
AR073452A1 (es) Proteinas de fusion que comprende dos o mas antigenos de leishmania y su uso en el diagnostico y tratamiento de leishmaniasis
BRPI0903506A8 (pt) “método de síntese de álcool para a síntese de butanol a partir de etanol”
MX2023001160A (es) Composicion farmaceutica del anticuerpo anti-pd-1 y uso del mismo.
ES2601028T3 (es) Método de medición inmunológica para el precursor del péptido liberador de gastrina
DK2287619T3 (da) Detektion af føtale celler fra moderens blod
ATE531529T1 (de) Wertdokument, herstellung und prüfung von wertdokumenten
ES2610081T3 (es) Estimación in vitro de eventos cardiovasculares mediante el ensayo para neo epitopos de la proteína Titin
BR112022014333A2 (pt) Anticorpos multiespecíficos para uso no tratamento de doenças
BR112022011291A2 (pt) Método para formar um conjugado de uma sulfonamida e um polipeptídeo
CO6290771A2 (es) Composiciones y vacunas que comprenden una cantidad inmunogenica de una proteina o un fragmento e la misma que comprende una determinante antigenica de reactividad cruzada
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело